Perimeter Medical Imaging Ai Inc (PYNKF)

$0.17 +0.00 (0.61%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 2,500
Avg Vol 42,418
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 10%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Perimeter Medical Imaging AI, Inc., a medical technology company, provides advanced imaging solutions to address unmet medical needs. The company offers the Perimeter S-Series optical coherence tomography (OCT) imaging system, which delivers high-resolution margin visualization of excised tissue specimens in the operating room. It is also developing the Perimeter B-Series OCT with ImgAssist artificial intelligence technology for patients undergoing breast conservation surgery. In addition, the c...

Industry: Medical Devices
Sector: Healthcare
Phone: 214-845-5154
Fax: 972-587-7795
Address:
555 Richmond Street West, Suite 511, Toronto, Canada
BioTuesdays
BioTuesdays Aug. 11 at 8:35 PM
$PYNKF sees 100% revenue growth in Q2-2025; reduces operating costs by ~30%; adds to leadership team; and creates IAB https://biotuesdays.com/2025/08/11/perimeter-sees-100-revenue-growth-in-q2-2025-reduces-operating-costs-by-30-adds-to-leadership-team-and-creates-iab/
0 · Reply
rudazur2
rudazur2 Aug. 11 at 8:24 PM
$PYNKF great ER
1 · Reply
rudazur2
rudazur2 Jul. 30 at 10:34 PM
$PYNKF close $5.35M raised at 0.3$ way higher than our current price of 0.18$ Financial 👌🏻 Insider buying on offering for $1M 👌🏻 Sales 👌🏻 NVIDIA partner 👌🏻 Next step FDA update about PMA H2 2025 ⏳️
1 · Reply
BioTuesdays
BioTuesdays Jul. 30 at 7:00 PM
Perimeter joins a select group of medtech innovators in the NVIDIA Connect program $PYNKF https://biotuesdays.com/2025/07/30/perimeter-joins-a-select-group-of-medtech-innovators-in-the-nvidia-connect-program/
0 · Reply
rudazur2
rudazur2 Jul. 30 at 11:33 AM
$PYNKF CEO buy for $1M on the offering, good news !
0 · Reply
BioTuesdays
BioTuesdays Jul. 30 at 12:03 AM
According to a press release issued by Perimeter Medical Imaging AI, it closed the final tranche of a prospectus offering of units of the company, in which its CEO, Adrian Mendes, participated to the tune of $1 million $PYNKF https://biotuesdays.com/2025/07/29/perimeter-ceo-significantly-adds-to-holdings/
0 · Reply
violinsoill
violinsoill Jul. 23 at 3:58 PM
$PYNKF Should grow wings and fly to $3.00 next month.
1 · Reply
rudazur2
rudazur2 Jul. 10 at 6:56 PM
$PYNKF hope to see approval in this quarter
1 · Reply
BioTuesdays
BioTuesdays Jul. 2 at 2:03 PM
Medical City Dallas Hospital enhances surgical precision with Perimeter’s OCT imaging technology $PYNKF https://biotuesdays.com/2025/07/02/medical-city-dallas-hospital-enhances-surgical-precision-with-perimeters-oct-imaging-technology/
0 · Reply
BioTuesdays
BioTuesdays Jun. 4 at 5:22 PM
Perimeter launches OCT-Tissue Registry to power AI and imaging innovation $PYNKF https://biotuesdays.com/2025/06/04/perimeter-launches-oct-tissue-registry-to-power-ai-and-imaging-innovation/
0 · Reply
Latest News on PYNKF
No data available.
BioTuesdays
BioTuesdays Aug. 11 at 8:35 PM
$PYNKF sees 100% revenue growth in Q2-2025; reduces operating costs by ~30%; adds to leadership team; and creates IAB https://biotuesdays.com/2025/08/11/perimeter-sees-100-revenue-growth-in-q2-2025-reduces-operating-costs-by-30-adds-to-leadership-team-and-creates-iab/
0 · Reply
rudazur2
rudazur2 Aug. 11 at 8:24 PM
$PYNKF great ER
1 · Reply
rudazur2
rudazur2 Jul. 30 at 10:34 PM
$PYNKF close $5.35M raised at 0.3$ way higher than our current price of 0.18$ Financial 👌🏻 Insider buying on offering for $1M 👌🏻 Sales 👌🏻 NVIDIA partner 👌🏻 Next step FDA update about PMA H2 2025 ⏳️
1 · Reply
BioTuesdays
BioTuesdays Jul. 30 at 7:00 PM
Perimeter joins a select group of medtech innovators in the NVIDIA Connect program $PYNKF https://biotuesdays.com/2025/07/30/perimeter-joins-a-select-group-of-medtech-innovators-in-the-nvidia-connect-program/
0 · Reply
rudazur2
rudazur2 Jul. 30 at 11:33 AM
$PYNKF CEO buy for $1M on the offering, good news !
0 · Reply
BioTuesdays
BioTuesdays Jul. 30 at 12:03 AM
According to a press release issued by Perimeter Medical Imaging AI, it closed the final tranche of a prospectus offering of units of the company, in which its CEO, Adrian Mendes, participated to the tune of $1 million $PYNKF https://biotuesdays.com/2025/07/29/perimeter-ceo-significantly-adds-to-holdings/
0 · Reply
violinsoill
violinsoill Jul. 23 at 3:58 PM
$PYNKF Should grow wings and fly to $3.00 next month.
1 · Reply
rudazur2
rudazur2 Jul. 10 at 6:56 PM
$PYNKF hope to see approval in this quarter
1 · Reply
BioTuesdays
BioTuesdays Jul. 2 at 2:03 PM
Medical City Dallas Hospital enhances surgical precision with Perimeter’s OCT imaging technology $PYNKF https://biotuesdays.com/2025/07/02/medical-city-dallas-hospital-enhances-surgical-precision-with-perimeters-oct-imaging-technology/
0 · Reply
BioTuesdays
BioTuesdays Jun. 4 at 5:22 PM
Perimeter launches OCT-Tissue Registry to power AI and imaging innovation $PYNKF https://biotuesdays.com/2025/06/04/perimeter-launches-oct-tissue-registry-to-power-ai-and-imaging-innovation/
0 · Reply
rudazur2
rudazur2 Jun. 3 at 3:16 PM
$PYNKF this year will be hard with multiple dilution. Don't buy and wait for better setup
0 · Reply
rudazur2
rudazur2 May. 29 at 2:00 PM
$PYNKF like I said previously, dilution was needed
1 · Reply
BioTuesdays
BioTuesdays May. 23 at 2:50 PM
Perimeter partners with Intermountain Health to study benefits of using OCT and AI to reduce cancer reoperations $PYNKF https://biotuesdays.com/2025/05/23/perimeter-partners-with-intermountain-health-to-study-benefits-of-using-oct-and-ai-to-reduce-cancer-reoperations/
0 · Reply
Gmac8625
Gmac8625 May. 15 at 2:21 AM
$PYNKF probably need another directionally positive quarter to generate some interest. Probably also need some Canadian interest in the story—Ontario is a winner take all market as are other provinces. Why this wouldn’t be in hospitals country wide I don’t know?
1 · Reply
BioTuesdays
BioTuesdays May. 14 at 5:34 PM
Social Capital’s Chamath Palihapitiya highlights latest developments on Perimeter Medical’s Next-gen, AI-driven B-Series OCT device on X $PYNKF https://biotuesdays.com/2025/05/14/social-capitals-chamath-palihapitiya-highlights-latest-developments-on-perimeter-medicals-next-gen-ai-driven-b-series-oct-device-on-x/
0 · Reply
rudazur2
rudazur2 May. 14 at 12:30 AM
$PYNKF great earning, great Q&A Growth acceleration and good sales pipeline. Anyway I will wait to see about the financial raise/dilution on Q2 before thinking to add more
0 · Reply
JBurckhardt
JBurckhardt May. 13 at 10:04 PM
$PYNKF https://ir.perimetermed.com/news-events/press-releases/detail/175/perimeter-medical-imaging-ai-announces-record-revenue-for
0 · Reply
BioTuesdays
BioTuesdays May. 13 at 3:47 PM
Radiology Today spotlights Perimeter’s next-gen, AI-enabled B-Series OCT for interoperative cancer margin assessment during breast-conserving surgeries $PYNKF https://biotuesdays.com/2025/05/13/radiology-today-spotlights-perimeters-next-gen-ai-enabled-b-series-oct-for-interoperative-cancer-margin-assessment-during-breast-conserving-surgeries/
0 · Reply
rudazur2
rudazur2 May. 12 at 10:25 PM
$PYNKF ER tomorrow after market. It will be very important since the financial situation is really bad and big chance we see dilution
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Mar. 26 at 8:31 PM
$PYNKF Q4 revenue up 303% YoY to $293K. Net loss narrows 35% to $3.4M. FDA PMA submission for B-Series OCT with AI – a pivotal milestone. Pivotal trial showed statistically significant reduction in residual cancer. Now in TN and NM hospitals. 9 S-Series placements in 2024 vs 3 in 2023. Cash $6.2M. CEO: 'Just approaching the starting line.' Scalpel-sharp progress. https://www.prnewswire.com/news-releases/perimeter-medical-imaging-ai-reports-fourth-quarter-and-full-year-2024-financial-results-and-provides-corporate-update-conference-callwebcast-today-at-5-pm-et-302412508.html
1 · Reply
rudazur2
rudazur2 Mar. 17 at 2:43 PM
$PYNKF great news
1 · Reply
BioTuesdays
BioTuesdays Mar. 17 at 1:56 PM
Perimeter Medical Imaging AI announced that it has filed a premarket approval (PMA) application for its next-generation B-Series OCT system, which combines proprietary AI technology with optical coherence tomography (OCT), for use during breast-conserving surgeries (BSC) in the U.S. $PYNKF https://biotuesdays.com/2025/03/17/perimeter-reaches-regulatory-milestone-with-fda-pma-submission-for-next-gen-b-series-oct-with-imgassist-ai-2-0/
0 · Reply